Affiliation:
1. Department of Food and Nutrition, Daegu University, Gyeongsan, Gyeongbuk, Republic of Korea
Abstract
Nonsmall cell lung cancer (NSCLC) accounts for approximately 80%–85% of all lung cancer patients. Gossypin, a flavonoid contained in Hibiscus vitifolius, has been reported as a potential anticancer agent. However, the effect of gossypin on NSCLC has not been elucidated. Herein, we evaluated the anticancer effects and investigated the molecular mechanisms of gossypin in NSCLC cell line, A549. We treated A549 cells with gossypin at different concentrations and performed cell viability and colony formation assays. As a result, gossypin inhibited cell proliferation. phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) is known to be involved in cancer cell growth. Additionally, p-PI3K/p-Akt reduces p21 expression, resulting in cell cycle progression. Therefore, the effects of gossypin on the expression of PI3K, Akt, and p21 were investigated via Western blot analysis. Gossypin inhibited p-PI3K/p-Akt and induced p21 expression. Also, gossypin induced the sub-G1 phase, which exhibits DNA fragmentation, indicating apoptosis. To corroborate these results, apoptosis and the expression of caspase-3 and poly ADP-ribose polymerase (PARP) were evaluated in gossypin-treated cells. Results showed that gossypin cleaved caspase-3 and PARP to induce apoptosis. Our study findings indicate a possible therapeutic effect of gossypin in NSCLC.
Funder
National Research Foundation of Korea
Subject
Complementary and alternative medicine,Plant Science,Drug Discovery,Pharmacology,General Medicine
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献